Mice sensitized intravenously with 300 Lg of BCG cell walls in Drakeol-Tween 80 and challenged intravenously 3 weeks later with 50 mg of old tuberculin released migration inhibitory factor (MIF) into the circulating blood in quantities that could be detected in serum dilutions of 1:64 to 1:128. When thymus-derived lymphocytes (T-cells) were absent at the time of sensitization, as in neonatally thymectomized mice or in athymic nude mice, detectable amounts of MIF were not formed. Sensitized mice treated with either anti-@ serum or anti-bone marrow-derived lymphocyte (B-cell) serum before intravenous challenge with old tuberculin released reduced amounts of MIF into the circulation. Mice lethally irradiated, reconstituted with B-cells, sensitized with BCG cell walls, and then challenged intravenously 3 weeks later with old tuberculin did not release MIF into the circulation. When T-cells were injected at least 10 days before challenge, however, MIF appeared.
Lymphokines, such as migration inhibitory factor (MIF) and type II interferon, are released into the circulation of mice that have been sensitized intravenously (i.v.) with Mycobacterium bovis strain BCG and then challenged i.v. with old tuberculin (OT) (11, 14) . The mice were appropriately sensitized with either living mycobacteria, dead mycobacteria, or cell wall fractions in oil droplets, and were challenged about 3 weeks later with either OT or living mycobacteria. Within 2 to 3 h after this i.v. challenge, MIF can be detected in the circulating blood, with serum dilutions of about 1:128 inhibiting the migration of normal macrophages by at least 20%. The MIF released into the circulation has been partly purified (11) and has been found to be acid unstable, heat stable, and highly specific (14) .
Of importance in the production of MIF may be the type or types of cells exposed to the antigen and the mode of interaction of these cells. Accordingly, experiments were initiated to determine (i) the source and types of cells involved in production of MIF and (ii) the experimental environment in vivo for maxum release of MIF. In this paper, experiments are described indicating that (i) thymus-derived lymphocytes (T-cells) must be present for 10 days before the time of challenge for MIF to be formed, and (ii) cells of both thymic and bone marrow (B-cells) origin are involved in the release of MIF in vivo into the circulation. Of four experiments (Table 2) , both the anti-@ and anti-B-cell sera partially but equally reduced the serum MIF titers compared with sera from control animals, which had been treated with either normal mouse or normal rabbit sera. The sera from mice treated with both anti-U and anti-B-cell sera had titers lower than the sera from mice receiving only one of the antisera.
X-irradiation, reconstitution, and production of serum MW. Total-body X-irradiation of guinea pigs or mice has been shown to inhibit the development of delayed hypersensitivity. The exact effect of such irradiation on the antigen-induced release of MIF into the circulation of sensitized mice is not known. Accordingly, mice were sensitized i.v. with 300 ug of BCG cell walls in oil droplets. Four weeks later, the mice received doses of total-body irra- As amounts of irradiation were increased above 50 rads, the MIF titer in the circulation decreased and ultimately became undetectable at X-ray doses of 1,000 rads. Detectable footpad reactions did not occur at irradiation doses of 200 rads and higher (Table 3) . Experiments were initiated to determine what type of lymphoid cells would restore the capacity of lethally irradiated mice to form MIF in the circulation system. C3H/He Dub mice were exposed to 900 rads of total-body X-irradiation, and within a few hours were reconstituted i.v. with 5 x 106 to 1 X 107 B-cells, obtained from femurs of normal C3H mice, or with both Bcells and 107 T-cells. Four days later, reconstituted mice and normal C3H mice were sensitized with BCG cell walls; they were challenged i.v. with OT 3 weeks later and exsanguinated 2 to 3 h later. Normal C3H mice were also challenged with OT and exsanguinated (Table 4).
Lethally irradiated mice reconstituted only with B-cells, and subsequently sensitized and challenged, did not have detectable quantities of MIF in their circulating blood. Lethally irradiated mice reconstituted with T-cells alone did not live long enough for the experiment to be completed. Lethally irradiated mice, however, that had been reconstituted with B-and T-cells released MIF into the blood in titers equivalent to those found in sensitized, non-irradiated animals. Since the foregoing experiments had suggested that both T-and B-cells were involved in the in vivo production of MIF, the question arose as to whether T-cells had to be present at the time of sensitization. Lethally irradiated mice were reconstituted with 107 B-cells, sensitized, challenged on day 21 after sensitization, and exsanguinated as above. At varying time intervals after sensitization but before challenge, different groups of mice were reconstituted i.v. with 107 T-cells (Table 5 ). In order for MIF to be formed and released into the blood, T-cells had to be present for at least 9 to 11 days before challenge. B-cells present for less than 9 to 11 days with T-cells in the lethally irradiated mice did not result in formation of MIF in the sensitized and challenged mice. Thus, at least a 10-day exposure of T-and B-cells was required before challenge for maximum MIF formation mn vivo.
DISCUSSION
MIF can be found in the blood of intact mice after i.v. sensitization with living BCG or with BCG cells or cell walls in oil droplets, i.v. challenge after a 3-week interval with OT, and exsanguination 2 to 3 h later (10, 11, 14) . The functional T-cell seems to play an essential role, since neither neonatally thymectomized mice nor athymic nude mice, sensitized and challenged, released detectable amounts of MIF in the blood. When, however, normal mice were sensitized but treated before challenge with anti-@ or anti-B-cell serum, a reduction in, but not an elimination of, MIF followed. Injection of both anti-@ and anti-B-cell serum, in contrast, caused a marked reduction in, if The activity of both B-and T-cells has been reported in the production of several lymphokines in vitro (8) . Human peripheral blood cells from individuals with delayed hypersensitivity to PPD, candida, or streptokinase-streptodornase were separated by affinity column chromatography and, after exposure to antigen, were assayed for their capacity to produce MIF and lymphocyte mitogenic factor. Both T-cell and B-cell fractions produced MIF to specific antigens, with B-cell supernatants exhibiting higher titers than the T-cells (7) . In contrast, lymphocyte mitogenic factor was synthesized only by the T-cell fraction, in response to the specific antigen. The lymphocyte mitogenic factor, however, induced blastogenesis in normal B-and Tcell fractions.
Chemotactic factor for monocytes has also been shown to be formed by T-cells (1) and BcelLs (13) . Although different stimulants may be necessary for each cell type, the release of a chemotactic lymphokine with the same activity follows.
The phytomitogens concanavalin A and phy- 
